Steering Committee
Amy Abernethy, M.D., Ph.D.
Former Principal Deputy Commissioner
FDA
Chris Arendt, Ph.D.
CSO, Head of Research
Takeda
Jamil Beg
Partner
SV Health Investors
Luciana Borio, M.D.
Venture Partner
Arch Venture Partners
Shelley Chu, M.D., Ph.D.
Partner, Head of Biotech
Lightspeed Ventures
Mark Currie, Ph.D.
Venture Partner
Iaso Ventures
Simone Fishburn, Ph.D.
VP & Editor in Chief
BioCentury Inc.
Todd Foley
Managing Director
MPM BioImpact
Kathleen Giacomini, Ph.D.
Dean, School of Pharmacy
UCSF
David Goldstein, Ph.D.
Co-founder & CEO
Actio Biosciences
Jane Grogan, Ph.D.
EVP, Head of Research
Biogen
Najat Khan, Ph.D.
Chief Data Science Officer
Johnson & Johnson
Olivier Leclerc
Senior Partner
McKinsey & Company
John Lepore, M.D.
CEO
ProFound Therapeutics
Mathai Mammen, M.D., Ph.D.
Chairman & CEO
FogPharma
Fiona Marshall, Ph.D.
President of Biomedical Research
Novartis
Antoine Papiernik
Chairman & Managing Partner
Sofinnova Partners
Kush Parmar, M.D., Ph.D.
Managing Partner
5AM Ventures
Cary Pfeffer, M.D.
Partner
Third Rock Ventures
Robert Plenge, M.D., Ph.D.
EVP, Chief Research Officer
Bristol Myers Squibb
Daniel Reich, M.D., Ph.D.
Senior Investigator, NIH Liaison
National Institute of Neurological Disorders and Stroke
Klaus Romero, M.D.
CEO
Critical Path Institute
David Satijn, Ph.D.
SVP, Head of Discovery
Genmab
Paul Peter Tak, M.D., Ph.D.
President and CEO
Candel Therapeutics
Douglas Williams, Ph.D.
Head of R&D
Sana Biotechnology